News
CMA fines Advanz over ‘excessive and unfair’ pricing of thyroid drug
The Competition and Markets Authority (CMA) in the UK has found that pharma company Advanz charged ‘excessive and unfair’ prices for supplying liothyronine tablets, a common medication used to treat thyroid hormone deficiency.